You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Unknown Primary

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

Recruiting
  • Unknown Primary Tumors
  • Oropharynx Cancer
  • Detection of lesions using fluorescence molecular imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 20, 2023

Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus

Recruiting
  • Cancer of Unknown Primary Site
  • +2 more
  • Transoral Ultrasound
  • Copenhagen, Denmark
  • +1 more
May 2, 2023

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Cancer of Unknown Primary Site Trial in Houston (Sintilimab)

    Recruiting
    • Cancer of Unknown Primary Site
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

    Not yet recruiting
    • Head and Neck Cancer
    • +2 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jan 18, 2023

    Carcinoma of Unknown Primary: A Comparison Across Tissue and

    Recruiting
    • Cancer of Unknown Primary Site
      • Bath, United Kingdom
      • +6 more
      Oct 18, 2022

      Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

      Active, not recruiting
      • Analgesia
      • +6 more
      • Copenhagen, Denmark
        Department of Otorhinolaryngology, Head and Neck Surgery & Audio
      Oct 14, 2022

      Integrated Molecular Profiling in Advanced Cancers Trial

      Active, not recruiting
      • Breast Cancer
      • +9 more
        • Toronto, Ontario, Canada
          Princess Margaret Hospital
        Sep 26, 2022

        Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)

        Recruiting
        • Cancer of Unknown Primary
        • +5 more
        • Tislelizumab plus chemotherapy
        • Shanghai, Shanghai, China
          ChangZheng Hospital
        Feb 6, 2022

        Cancer of Unknown Primary Site Trial in Shanghai (tissue-of-origin (ORIGIN-PanCA?R) profiling)

        Completed
        • Cancer of Unknown Primary Site
        • tissue-of-origin (ORIGIN-PanCA○R) profiling
        • Shanghai, China
          Fudan University Cancer Hospital
        Jan 21, 2022

        Cancer of Unknown Primary Site Trial in Bendigo, Melbourne, Warrnambool (68Ga-FAPi-46, PET/CT imaging)

        Not yet recruiting
        • Cancer of Unknown Primary Site
        • Bendigo, Victoria, Australia
        • +2 more
        Feb 28, 2022

        Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

        Recruiting
        • Carcinoma of Unknown Primary
        • Pembrolizumab Injection
        • Calgary, Alberta, Canada
        • +2 more
        Feb 18, 2022

        Solving Riddles Through Sequencing

        Recruiting
        • Leukemia
        • +5 more
        • Next Generation Sequencing
        • Munich, Germany
          MLL Munich Leukemia Laboratory
        Jan 19, 2022

        Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

        Recruiting
        • Breast Cancer
        • +10 more
          • Hamilton, Ontario, Canada
          • +6 more
          Apr 21, 2022

          First-line Treatment Among Cancer of Unknown Primary in China

          Recruiting
          • Cancer of Unknown Primary Site
          • no intervention
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cencer Center
          Jul 6, 2021

          Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

          Recruiting
          • Malignant Digestive System Neoplasm
          • +12 more
          • Computed Tomography
          • +4 more
          • Houston, Texas
            M D Anderson Cancer Center
          Sep 22, 2022

          Solid Tumor, Microsatellite Instability, Mismatch Repair Deficiency Trial in Australia (APL-501)

          Completed
          • Solid Tumor
          • +3 more
          • Camperdown, New South Wales, Australia
          • +4 more
          May 5, 2022

          Rare Cancers, Cholangiocarcinoma, Cancer of Unknown Primary Site Trial in Cambridge (FoundationOne CDx and FoundationOne Liquid

          Recruiting
          • Rare Cancers
          • +2 more
          • FoundationOne CDx and FoundationOne Liquid CDx
          • Cambridge, Massachusetts
            TargetCancer Foundation
          Oct 13, 2021

          Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

          Recruiting
          • Neuroendocrine Tumors
          • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Jan 19, 2023

          Breast Carcinoma, Digestive System Tumor, Malignant Brain Tumor Trial in Scottsdale, Jacksonville (Biospecimen Collection,

          Active, not recruiting
          • Breast Carcinoma
          • +10 more
          • Biospecimen Collection
          • +3 more
          • Scottsdale, Arizona
          • +1 more
          Feb 17, 2022

          Circulating Biomarkers in Oropharyngeal Cancers

          Active, not recruiting
          • Oropharynx Squamous Cell Carcinoma
          • +3 more
            • Orebro, Sweden
              Anna Oldaeus Almerén
            Jun 13, 2023

            Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

            Recruiting
            • Pulmonary Neuroendocrine Neoplasm
            • +9 more
            • Houston, Texas
              Excel Diagnostics and Nuclear Oncology Center
            Jul 9, 2021

            NRG1, NRG1 Fusion, Pancreatic Cancer Trial (MCLA-128)

            Available
            • NRG1
            • +11 more
            • (no location specified)
            Jul 21, 2021

            Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

            Recruiting
            • Adenocarcinoma
            • +75 more
            • Biomarker Testing (L)
            • +2 more
            • Idaho Falls, Idaho
            • +1 more
            Oct 18, 2022

            Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

            Recruiting
            • Non Small Cell Lung Cancer
            • +6 more
            • Fairfax, Virginia
              NEXT Oncology
            Jun 7, 2023